Premium
Pharmacologic treatments for esophageal disorders
Author(s) -
Blackshaw L. Ashley,
Bordin Dmitry S.,
Brock Christina,
Brokjaer Anne,
Drewes Asbjørn Mohr,
Farmer Adam D.,
Krarup Anne Lund,
Lottrup Christian,
Masharova Antonina A.,
Moawad Fouad J.,
Olesen Anne Estrup
Publication year - 2014
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/nyas.12520
Subject(s) - gerd , medicine , esophagus , esophageal disorder , reflux , gastroenterology , esophageal disease , baclofen , disease , receptor , agonist
The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the role for ketamine and other alternative treatments in esophageal disorders; the use of linaclotide in the treatment of esophageal pain; the alginate test as a diagnostic criterion in gastroesophageal reflux disease (GERD); the use of baclofen in treatment of GERD; the effects of opioids on the esophagus; the use of antagonists on the receptor level in GERD; the effect of local formulation of drugs on the esophageal mucosa; and the use of electroencephalographic fingerprints to predict the effect of pharmacological treatment.